Pfizer bets on gene therapy as technology comes of age

LONDON (Reuters) – Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks.

—> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *